THANK YOU FOR SUBSCRIBING
Pharma Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Pharma Tech Outlook
HOF Sonderanlagenbau has been a trusted one-stop shop in the freeze-drying technology industry for over 35 years. Specializing in the manufacturing of custom freeze-drying systems, loading and unloading systems, and freeze-thaw equipment, HOF is known for its innovation, reliability and dedication to environmental sustainability. Its systems, powered by state-of-the-art technology, are built to perform reliably for more than 20 years. “We provide reliable, high-quality equipment that consistently fulfill customer requirements,” says Fabian Plaum, sales manager at HOF. The HOF team comprises experts specializing in various freeze-drying applications in pharmaceuticals and biotechnology. This wealth of knowledge is leveraged to build an end product that is truly innovative and dependable. Outstanding, 24/7 service supports that long-term reliability. Coupled with a steadfast focus on cutting-edge technology, HOF is setting new standards in the industry, meeting the evolving needs of its clients while prioritizing environmental protection. The Future of Eco-Friendly Freeze-Drying Solutions Going beyond traditional freeze-drying solutions, HOF offers a comprehensive range of services that reduce overall energy consumption, leading to a more sustainable process for its customers. A key aspect is the use of state of the art and energy-reducing refrigeration technology, which saves energy and reduces operational costs. HOF systems do not consume energy when not in use, and are always developed to the latest state of the art technology. This is a massive benefit to clients because it assists them in enhancing efficiency while simultaneously hitting their sustainability goals. “In general the freeze-drying process is a very energy consuming process in order to make a product long-term stable and allow for a storage of the product. At HOF we are therefore working on solutions that reduce the energy requirements and increase the energy efficiency of the system while keeping the high-quality standards alive,” says Fabian Plaum. HOF’s expertise lies in manufacturing three key alternative refrigeration methods: hydrocarbons (ethane and propene) through a two-cascade system called CAR6, liquid nitrogen, and the CryoBlizzard technology, which utilizes air as a natural refrigerant. The CryoBlizzard system stands out for its innovative use of air to achieve ultra-low temperatures below -80 °C. This closed cold air machine operates efficiently at partial load and does not contribute to climate change, meeting stringent environmental regulations in both Europe and the U.S. It is crucial to go beyond presenting concepts on paper with real-world references and prototypes. HOF demonstrates its commitment to thoroughly testing and refining its solutions before they reach the customer.
Philipp Osl, CEO, Christoph Bamert, Head of Sales and Marketing
In today’s rapidly evolving global cold chain, companies like ELPRO have managed to innovate while providing customers with fully compliant solutions for highly regulated environments. For over 35 years, the company has provided environmental monitoring data intelligence, hardware, SaaS and on-premise software and GxP services to the world’s leading pharmaceutical, life sciences, health care and logistics companies. As a global market leader, ELPRO continually innovates with scalable solutions at every level in the supply chain. From cloud-based, wireless, IoT sensors and smart electronic boxlevel indicators to bespoke integrated enterprise solutions, ELPRO knows instant access to actionable data is key to managing today’s complex global supply chains. “We bring customers process efficiency, easy no-touch handling, and the lowest total cost of ownership,” says Philipp Osl, CEO, ELPRO. “Our solutions provide quality assurance across the entire supply chain in a secure, compliant environment, and consequently peace of mind for our customers.” Hallmarks of ELPRO’s business are its dedication to the pharma industry and its customer-centric approach. “People are truly the key to our success and what drives our business forward,” Osl notes. “Our product innovation and customer service teams, as well as global business partners, all possess a deep understanding of the unique challenges in the pharmaceutical cold chain. We are fully aligned to continuously meet customer requirements every step of the way.” Over Three Decades of Solving Customer Challenges Over the past 35 years, there are numerous success stories where ELPRO has helped clients overcome compliance challenges. “One of the most interesting was a complete software integration with SAP data and automated assessments based on product stability.This helped our customer reduce manual processes, and gave them the flexibility to perform fully automated product stability assessments on temperature data,” Osl says. “The implementation was a huge success. Thanks to our customizable liberoMANAGER, we adapted unique customer processes and improved where they had pain points.”
Freeze Drying System
Ross Jeggo, Therapeutic Area Head at Servier
Pharma Consulting
Ivanna M. Rosendal, Global Head of Digitalization, Ascendis Pharma
Freeze Drying System
Patrick Nieuwenhuizen, Director and Senior Consultant at PharmaLex
Freeze Drying System
Rafał Łunio PhD, R&D Director and Kamil Szala, Analytical Scientist at Polfa Tarchomin SA
Freeze Drying System
Yan Zhi, Director, Cell & Gene Therapy Product Owner, CSL
Freeze Drying System
Léa Sorret, Principal Scientist & Group Lead in Pharmaceutical Development, Lonza
Freeze Drying System
Antti Haapalinna, Vice President, External Science and Partnering, R&D, Orion Corporation
Pharmaceutical manufacturing faces energy-intensive freeze drying, affecting profitability and sustainability.
Freeze drying, an essential technique for preserving sensitive biologics, has become a cornerstone of the European pharmaceutical industry.
Preserving Pharma Innovations with Next-Gen Freeze Drying
As the demand for high-quality pharmaceuticals grows, solution providers are stepping up to meet the pharma sector’s stringent regulatory and sustainability requirements. They offer advanced technologies that enhance the efficiency and reliability of freeze-drying processes while navigating these complexities.
Modern freeze-drying systems integrate automation to monitor critical parameters like temperature and pressure in real time, reducing human intervention and enhancing precision. At the same time, they offer enhanced data-driven tools that provide better insights into the drying process, enabling manufacturers to optimize efficiency and lower energy consumption. The market is also witnessing game-changing advances in equipment design, particularly in tray freeze dryers, which are helping shorten cycle times and improve performance--crucial given the long processing time traditionally associated with freeze drying.
This edition of Pharma Tech Outlook Europe explores the leading freeze drying systems providers and highlights their expertise and the partnerships they forge to enhance product quality while driving the industry’s commitment to operational excellence and environmental sustainability. It features thought leadership articles from Ivanna M. Rosendal, Global Head of Digitalization Ascendis Pharma, who stresses that pharmaceutical companies should reorganize around value streams rather than traditional functional departments to enhance innovation, reduce costs and accelerate drug development. It also includes insights from Yan Zhi, Director of Cell & Gene Therapy Product Owner, CSL, who emphasizes the need for enhanced collaboration between CDMOs and CROs to address CMC challenges and support the evolving landscape of gene therapy products.
The edition also spotlights HOF Sonderanlagenbau, which designs and manufactures custom freeze-drying systems and related equipment, focusing on innovative and reliable solutions for the pharmaceutical and biotechnology industries. The company emphasizes energy-efficient technologies, in-house manufacturing, and exceptional customer service to meet the evolving needs of its clients while prioritizing environmental sustainability.
We hope this edition of Pharma Tech Outlook Europe provides valuable insights to assist you in finding the right partner for your organization. Let us know your thoughts!
